Abstract: The current marking gauges, mortise gauges and circle marking gauges on the market require use of a ruler to measure distances prior to marking, which is inconvenient and time consuming. Moreover, the accuracy of the marked dimension is inexact due to the low accuracy of using a ruler. Furthermore, parallax error created by transferring the measured distance between the rule and the gauges also needs to be accounted for, which reduces accuracy even further. This present invention helps to improve the accuracy of the measurement and marking of the gauges, increases efficiency, convenience, saves time and is easy to use. The new product is a digital multifunctional marking gauge, that includes a Digital Unit, Main Slider, Beam, Display, Fixed Pin, Adjustable Pin, Adjustment Slider, Fence, Calibration Frame, Calibration bar, Setting Block, Scriber, Set function button of the Digital Unit, Locking Screw, Fixing Screws and related components.

Abstract: The current marking gauges, mortise gauges and circle marking gauges on the market require use of a ruler to measure distances prior to marking, which is inconvenient and time consuming. Moreover, the accuracy of the marked dimension is inexact due to the low accuracy of using a ruler. Furthermore, parallax error created by transferring the measured distance between the rule and the gauges also needs to be accounted for, which reduces accuracy even further. This present invention helps to improve the accuracy of the measurement and marking of the gauges, increases efficiency, convenience, saves time and is easy to use. The new product is a digital multifunctional marking gauge, that includes a Digital Unit, Main Slider, Beam, Display, Fixed Pin, Adjustable Pin, Adjustment Slider, Fence, Calibration Frame, Calibration bar, Setting Block, Scriber, Set function button of the Digital Unit, Locking Screw, Fixing Screws and related components.

Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.

Abstract: This invention relates to, among other items, 6-substituted benzoxaborole compounds and their use for treating bacterial infections.

Abstract: The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.

Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.

Abstract: The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.

Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.

Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds, their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases, including proliferative diseases, inflammatory and obstructive airways diseases, allergic conditions, autoimmune and cardiovascular diseases.

Abstract: The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.

Abstract: A high-speed measuring electronic digital outside micrometer allowing a user to make measurements quickly and effectively compared to conventional electronic outside micrometers with rotary thread spindles, which have limited measuring speed. This high-speed measuring electronic digital outside micrometer features: a linear motion digital sensor, a linear scale digital sensor, a linear motion digital sensor base, a digital display unit, an electronic processing unit, a micrometer body, a linear spindle, a linear spindle movement unit, a spindle control unit, a micrometer anvil, and retractable springs. In a stationary position, the measuring surface of the micrometer anvil and the linear spindle are in contact to the other. By operating the spindle control unit, it will create distance between the micrometer anvil and the linear spindle measuring surface. This distance is a measurable distance of the micrometer.

Abstract: This invention relates to, among other items, 6-substituted benzoxaborole compounds and their use for treating bacterial infections.

Abstract: This invention relates to, among other items, 6-substituted benzoxaborole compounds and their use for treating bacterial infections.

Abstract: A multiple function electronic digital measuring gauge with the following features: two measuring arms (Arm 1 and Arm 2), a rotary motion capacitive sensor unit, which include two rotary motion sensors (First Sensor and Second Sensor), an electronic processor unit, and an electronic digital display unit. First Sensor is mounted on Arm 1, and Second Sensor is mounted on Arm 2. With the movement of the two arms, the data created by the capacitive sensor unit is transferred to the electronic processor, which then computes the data into readable data and displays it on the electronic digital display unit. The reading represents the distance between the two measuring arms created by the arm movements. This invention has the following advantages: accurate, easy to operate, time saving, economical, convenient, and multifunctional.

Abstract: This invention provides, among other things, novel compounds useful for treating bacterial infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.